Cellectis Sa Stock Target Price
| CLLS Stock | USD 1.87 0.01 0.54% |
Cellectis SA fundamentals help investors to digest information that contributes to Cellectis' financial success or failures. It also enables traders to predict the movement of Cellectis Stock. The fundamental analysis module provides a way to measure Cellectis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellectis stock.
Cellectis |
Cellectis Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellectis' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellectis could also be used in its relative valuation, which is a method of valuing Cellectis by comparing valuation metrics of similar companies.Cellectis is currently under evaluation in target price category among its peers.
Cellectis Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (2.34) % | ||||
| Operating Margin | (0.60) % | ||||
| Current Valuation | 11.48 M | ||||
| Shares Outstanding | 100.09 M | ||||
| Shares Owned By Insiders | 3.86 % | ||||
| Shares Owned By Institutions | 14.60 % | ||||
| Number Of Shares Shorted | 156.19 K | ||||
| Price To Earning | (14.84) X | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 5.19 X | ||||
| Revenue | 755 K | ||||
| Gross Profit | 23.95 M | ||||
| EBITDA | (98.09 M) | ||||
| Net Income | (116.83 M) | ||||
| Cash And Equivalents | 153.13 M | ||||
| Cash Per Share | 3.37 X | ||||
| Total Debt | 92.85 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 3.17 X | ||||
| Book Value Per Share | 1.29 X | ||||
| Cash Flow From Operations | (24.75 M) | ||||
| Short Ratio | 3.28 X | ||||
| Earnings Per Share | (1.16) X | ||||
| Target Price | 6.5 | ||||
| Number Of Employees | 216 | ||||
| Beta | 3.2 | ||||
| Market Capitalization | 187.18 M | ||||
| Total Asset | 334.27 M | ||||
| Retained Earnings | (405.76 M) | ||||
| Working Capital | 77.86 M | ||||
| Current Asset | 51 M | ||||
| Current Liabilities | 26.28 M | ||||
| Net Asset | 334.27 M |
About Cellectis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellectis SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellectis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellectis SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.